Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-27

Link:

https://api.zotero.org/groups/2494380/items/TLAQPAWG?format=atom

Updated:

11/27/2020, 08:56

From feeds:

[sandbox] K4D COVID-19 Resource Hub » Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

11/27/2020, 16:43

Date published:

11/27/2020, 08:55